Voyager Therapeutics (VYGR) Other Working Capital Changes (2014 - 2026)

Voyager Therapeutics has reported Other Working Capital Changes for 11 years, with the latest figure at -$1.2 million in Q1 2026.

• Quarterly Other Working Capital Changes rose 73.69% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.9 million (up 89.98% YoY) and the FY2025 annual result came in at -$7.2 million, up 83.88% from the prior year.
• Other Working Capital Changes grew to -$1.2 million in Q1 2026 per VYGR's latest filing, from -$1.9 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.7 million in Q2 2025 and troughed at -$3.2 million in Q3 2025.
• A 5-year average of $25294.1 and a median of -$191000.0 in 2022 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2022 and 2024: Other Working Capital Changes surged 3196.54% in 2022, then slumped 5802.05% in 2024.
• Over 5 years, Other Working Capital Changes stood at -$3.8 million in 2022, then surged by 80.62% to -$731000.0 in 2023, then plunged by 5802.05% to -$43.1 million in 2024, then jumped by 95.67% to -$1.9 million in 2025, then surged by 36.06% to -$1.2 million in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.2 million, -$1.9 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.